SINGAPORE: More than 18,000 doses of Novavax’s Nuvaxovid COVID-19 vaccine have been administered as of Aug 31, with five cases of severe side effects reported.
In its 13th vaccine safety report on Monday (Sep 19), the Health Sciences Authority said there were 28 reports of adverse reactions, of which 82 per cent – or 23 cases – were not serious.
This included allergic reactions such as rash and eye swelling, numbness, inflammation of blood vessels, dizziness and chest pain.
“These were largely consistent with what were reported in the clinical studies or with other COVID-19 vaccines,” HSA said. Common side effects that recipients may experience include injection site pain and/or tenderness, fatigue, headache and muscle pain.
HSA granted interim authorisation to t